Brett Matthew Hall is CHIEF SCIENTIFIC OFFICER of Immuneering Corp. Currently has a direct ownership of 345,896 shares of IMRX, which is worth approximately $691,792. The most recent transaction as insider was on Mar 20, 2024, when has been sold 7,000 shares (Class A Common Stock) at a price of $2.86 per share, resulting in proceeds of $20,020. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 346K
0% 3M change
3.97% 12M change
Total Value Held $691,792

Brett Matthew Hall Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 20 2024
BUY
Open market or private purchase
$20,020 $2.86 p/Share
7,000 Added 1.98%
345,896 Class A Common Stock
Mar 15 2024
BUY
Grant, award, or other acquisition
$10,061 $1.62 p/Share
6,211 Added 1.8%
338,896 Class A Common Stock
May 25 2022
BUY
Open market or private purchase
$10,000 $3.92 p/Share
2,551 Added 0.76%
332,685 Class A Common Stock
Mar 23 2022
BUY
Open market or private purchase
$8,305 $7.91 p/Share
1,050 Added 0.32%
330,134 Class A Common Stock
Dec 22 2021
BUY
Grant, award, or other acquisition
-
322,691 Added 49.51%
329,084 Class A Common Stock
Aug 03 2021
BUY
Open market or private purchase
$20,295 $15.0 p/Share
1,353 Added 17.47%
6,393 Class A Common Stock
Aug 03 2021
BUY
Conversion of derivative security
-
5,040 Added 50.0%
5,040 Class A Common Stock
BMH

Brett Matthew Hall

CHIEF SCIENTIFIC OFFICER
Cambridge, MA

Track Institutional and Insider Activities on IMRX

Follow Immuneering Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMRX shares.

Notify only if

Insider Trading

Get notified when an Immuneering Corp insider buys or sells IMRX shares.

Notify only if

News

Receive news related to Immuneering Corp

Track Activities on IMRX